Protara Therapeutics Inc

Research Protara Therapeutics Inc (TARA) on Bullrun: market cap USD 233.81M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTARA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 233.81M
• Financial periodFY2025
• Net income-USD 57.40M
• Free cash flow-USD 56.46M

Valuation Snapshot

latest market cap is USD 233.81M.

About Protara Therapeutics Inc

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations.

Frequently asked questions

What is Protara Therapeutics Inc's market cap?

Protara Therapeutics Inc's market capitalization is USD 233.81M.

What does Protara Therapeutics Inc do?

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.